<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02158156</url>
  </required_header>
  <id_info>
    <org_study_id>H2-2013-066(A)</org_study_id>
    <nct_id>NCT02158156</nct_id>
  </id_info>
  <brief_title>Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy</brief_title>
  <official_title>Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to investigate if patients with Oculopharyngeal Muscular Dystrophy can
      improve fitness by home-training on a cycle ergometer 30 minute, 3 times a week for 10 weeks.

      Participants will be evaluated on maximal oxygen consumption and maximal workload measured by
      an incremental test at baseline and at the end of the exercise period.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy based on VO2max</measure>
    <time_frame>10 weeks</time_frame>
    <description>Difference in VO2max measured before and after intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SF-36 Questionaire</measure>
    <time_frame>10 weeks</time_frame>
    <description>Changes in self-rated health from baseline to end of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 minute walk test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Changes in walking distance from baseline to end of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity in maximal load (Watt)</measure>
    <time_frame>10 weeks</time_frame>
    <description>Changes in maximal load (watt) in the VO2max-test from baseline to end of intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of plasma creatine kinase</measure>
    <time_frame>10 weeks</time_frame>
    <description>Marker for exercise-induced muscle damage. Taken week 0,3 and 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of plasma myoglobin</measure>
    <time_frame>10 weeks</time_frame>
    <description>Marker for excercise-induced muscle damage, taken week 0, 3 and 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 minute walk test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Changes in walking distance in the test from baseline to end of intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A five-time-repetition-sit-to-stand-test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Changes in time of five repetitions from baseline to end of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A 14-step-stair-test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Changes in time completing the test from baseline to end of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamometry</measure>
    <time_frame>10 weeks</time_frame>
    <description>Changes in external force production from baseline to end of intervention. Dynamometry are measured on hip flexion, dorsal foot flexion, plantar foot flexion, knee flexion, knee extension, and elbow flexion.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Oculopharyngeal Muscular Dystrophy</condition>
  <arm_group>
    <arm_group_label>Excercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 weeks of home training on a cycle-ergometer. Exercise 30 minutes every other day or at least three times a week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Ten weeks of home-training on a cycle ergometer 3 times a week for 30 minutes.</description>
    <arm_group_label>Excercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Danish patients with Oculopharyngeal muscular dystrophy

        Exclusion Criteria:

          -  Patients who are too week to train on an cycle-ergometer for 10 weeks

          -  Patients with other health issues wich confound the interpretation of the efficacy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen BH Pedersen, Bsc.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neuromuscular Research Unit, Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neuromuscular Research Unit</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vissing</last_name>
      <phone>+4535451842</phone>
    </contact>
    <investigator>
      <last_name>Karen BH Pedersen, Med. student, Bsc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.neuromuscular.dk</url>
    <description>Website of the Neuromuscular Research Unit, Rigshospitalet, Copenhagen, Denmark</description>
  </link>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2014</study_first_submitted>
  <study_first_submitted_qc>June 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2014</study_first_posted>
  <last_update_submitted>June 5, 2014</last_update_submitted>
  <last_update_submitted_qc>June 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Karen Brorup Heje Pedersen</investigator_full_name>
    <investigator_title>Bsc Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Oculopharyngeal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

